Drs. Moslehi & Johnson discuss Cardiac irAEs updates from #AHA21: https://bit.ly/31LJaP3

Drs. Moslehi & Johnson discuss Cardiac irAEs updates from #AHA21: https://bit.ly/31LJaP3Подробнее

Updating Our Cardio-Oncology Skills in the Cancer Immunotherapy Era: Management of Cardiac irAEsПодробнее

Dr Javid Moslehi at HFA Winter Meeting 2019Подробнее

Ramon Quesada, M.D. | Miami Cardiac & Vascular InstituteПодробнее

Dissecting Toxicities of Immune Checkpoint Inhibitors with Dr. Douglas Johnson, M.D., MSCIПодробнее

Robert Gish, MD | The impact of HDV on health-related quality of life and fatigue in patientsПодробнее

Sandra Chaparro, M.D. | Miami Cardiac & Vascular InstituteПодробнее

SITC clinical practice guidelines on immune checkpoint inhibitor-related adverse eventsПодробнее

Drs. Moslehi & Johnson discuss #CardioOnc at #AHA22 - https://bit.ly/3TiM0QNПодробнее

The current state of cardiac transplantation for AL and ATTR amyloidosisПодробнее

Ask the Experts: Acute Illness and VaccinationПодробнее

Autoimmune diseaseПодробнее

Heart Failure: New Treatments and TechПодробнее

Your Heart Health is a PriorityПодробнее

A shot of hope: Doctors reflect on vaccine and treatment a year after the pandemicПодробнее

Outcomes & promising treatment options following HMA failure in patients with HR-MDSПодробнее

ICC guideline revisions for patients with MDS: improving diagnosis in MDSПодробнее

Dagmar Hernandez Suarez, M.D. | Treatments for Coronary Microvascular DiseaseПодробнее

Current and future treatment approaches for HR-MDSПодробнее